WO2026033380 - PROCESS FOR PREPARING OLIGOSACCHARIDE COMPLEXES
National phase entry is expected:
Publication Number
WO/2026/033380
Publication Date
12.02.2026
International Application No.
PCT/IB2025/057923
International Filing Date
04.08.2025
Title **
[English]
PROCESS FOR PREPARING OLIGOSACCHARIDE COMPLEXES
[French]
PROCESSUS DE PRÉPARATION DE COMPLEXES OLIGOSACCHARIDIQUES
Applicants **
BIONTECH SE
Inventors
APRICENO, Azzurra
TIWARI, Neha
THANKI, Kaushik
Priority Data
63/679,468
05.08.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4918 | |
| EPO | Filing, Examination, Granting | 42772 | |
| Japan | Filing, Examination, Granting | 3507 | |
| South Korea | Filing, Examination, Granting | 4706 | |
| USA | Filing, Examination, Granting | 14290 |
Total:
70,193
Contact Us
Abstract[English]
The present disclosure provides methods and systems for preparing a pharmaceutical composition comprising a plurality of nucleic acid particles, the method comprising contacting a nucleic acid solution with an organic solution via a mixer configured to receive the nucleic acid solution and the organic solution, wherein: the organic solution comprises an organic solvent and an oligosaccharide comprising one or more cationic moieties.[French]
La présente divulgation propose des procédés et des systèmes de préparation d'une composition pharmaceutique comprenant une pluralité de particules d'acide nucléique, le procédé consistant à mettre en contact une solution d'acide nucléique avec une solution organique par l'intermédiaire d'un mélangeur configuré pour recevoir la solution d'acide nucléique et la solution organique, la solution organique comprenant un solvant organique et un oligosaccharide comprenant une ou plusieurs fractions cationiques.